NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 241 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $423,661 | -19.3% | 30,560 | -8.5% | 0.00% | 0.0% |
| Q1 2024 | $525,079 | -12.5% | 33,402 | -10.0% | 0.00% | 0.0% |
| Q4 2023 | $600,230 | +35.1% | 37,097 | +2.7% | 0.00% | 0.0% |
| Q3 2023 | $444,387 | -35.1% | 36,129 | -15.2% | 0.00% | -50.0% |
| Q2 2023 | $684,667 | +85057.6% | 42,606 | -7.7% | 0.00% | 0.0% |
| Q1 2023 | $804 | +57.6% | 46,177 | -16.4% | 0.00% | 0.0% |
| Q4 2022 | $510 | -99.9% | 55,238 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $475,000 | +13.6% | 55,210 | +7.4% | 0.00% | 0.0% |
| Q2 2022 | $418,000 | -31.5% | 51,394 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $610,000 | -62.1% | 50,239 | +6.5% | 0.00% | -71.4% |
| Q4 2021 | $1,609,000 | -36.0% | 47,156 | -9.6% | 0.01% | -46.2% |
| Q3 2021 | $2,516,000 | +7.5% | 52,165 | +0.7% | 0.01% | -13.3% |
| Q2 2021 | $2,340,000 | -8.8% | 51,814 | -2.6% | 0.02% | -16.7% |
| Q1 2021 | $2,565,000 | – | 53,192 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 2,683,090 | $11,188,000 | 6.34% |
| GROW Partners, LLC | 1,140,300 | $4,755,000 | 4.35% |
| KOPP INVESTMENT ADVISORS LLC | 1,592,832 | $6,642,000 | 3.19% |
| PERKINS CAPITAL MANAGEMENT INC | 816,680 | $3,406,000 | 2.92% |
| 1492 Capital Management LLC | 786,495 | $3,280,000 | 2.05% |
| Curi RMB Capital, LLC | 4,177,053 | $17,418,000 | 1.06% |
| BARD ASSOCIATES INC | 491,100 | $2,048,000 | 0.96% |
| FALCON POINT CAPITAL, LLC | 162,475 | $678,000 | 0.62% |
| THB ASSET MANAGEMENT | 2,214,203 | $9,233,000 | 0.61% |
| NORTHPOINTE CAPITAL LLC | 1,033,821 | $4,311,000 | 0.52% |